Capitol Family Office’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
Capitol Family Office's LLY Position: Q2 2026 in Review
Capitol Family Office reduced its Eli Lilly (LLY) stake by 5.2% in Q2 2026, selling an estimated $116K and leaving 2,060 shares worth $2.47M. The position accounts for 2.61% of the portfolio, ranked #6.
Capitol Family Office first reported a position in LLY in Q3 2023 and has held it in 12 quarters since. The position peaked at $2.94M in Q2 2024. 2,821 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Capitol Family Office held 2,060 shares of Eli Lilly worth $2.47M as of Q2 2026.
- Capitol Family Office sold 114 Eli Lilly shares in Q2 2026, an estimated $116K.
- Eli Lilly made up 2.61% of Capitol Family Office's portfolio in Q2 2026, its #6 holding.
- Capitol Family Office first reported a position in Eli Lilly in Q3 2023 and has held it in 12 quarters since.
- Capitol Family Office's Eli Lilly position peaked at $2.94M in Q2 2024.
- 2,821 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Capitol Family Office's 13F filing for Q2 2026, filed 31 Jul 2026.